Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinacrine + Capecitabine in Advanced Colorectal Adenocarcinoma
NCT01844076Phase 2Terminated
- Sponsor
- Fox Chase Cancer Center
- Start
- Jan 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of quinacrine in colorectal adenocarcinoma, sponsored by Fox Chase Cancer Center. Started Jan 2016; status: terminated.
02
Drugs
quinacrine
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT01844076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844076.